SGLT2 inhibitors across various patient populations in the era of precision medicine: the multidisciplinary team approach

SGLT2 inhibitors across various patient populations in the era of precision medicine: the multidisciplinary team approach

Abstract Sodium-glucose cotransporter-2 inhibitors have revolutionized the management of a variety of diseases. Initially developed to address glycemic control in diabetes, sodium-glucose cotransporter-2 inhibitors were identified for their ability to inhibit glucose reabsorption in the kidneys. Lan...

Full description

Saved in:
Bibliographic Details
Main Authors: Patrick McLean, Josiah Bennett, Edward “Trey” Woods, Sanjay Chandrasekhar, Noah Newman, Yusuf Mohammad, Muzamil Khawaja, Affan Rizwan, Riyan Siddiqui, Yochai Birnbaum, Carl J. Lavie, Salim Virani, Karim El Hachem, W. H. Wilson Tang, Tania Ahuja, Scott Isaacs, Chayakrit Krittanawong
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:npj Metabolic Health and Disease
Online Access:https://doi.org/10.1038/s44324-025-00068-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s44324-025-00068-z

Similar Items